Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Delayed NSE India S.E. Other stock markets 10:28:58 12/06/2026 BST			5-day change	1st Jan Change
2,408.10 ^INR	+3.31%		+18.42%	+30.98%

05-15	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	177,168	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	16.39%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	177,168	177,168	177,168
Change	-	68.55%	-12.11%	120.88%	52.16%	16.39%	0%	0%
P/E Ratio	12.7x	17.3x	12.1x	22x	28.5x	17.9x	24.8x	21.8x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.03x	3.66x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.6x	1.6x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.12x	6.32x
EV / Revenue	0x	0x	0x	0x	0x	8.33x	7.12x	6.32x
EV / EBITDA	0x	0x	0x	0x	0x	23.9x	20.6x	18.1x
EV / EBIT	0x	0x	0x	-	0x	22.8x	19x	16.5x
EV / FCF	0x	0x	0x	0x	0x	46.6x	32.2x	32.7x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	3.1%	3.06%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.17%	0.17%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,330.80	2,330.80	2,330.80
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	06/05/21	12/05/22	27/05/23	16/05/24	15/05/25	14/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.01x	7x	23.88x	0.84%	44.96B
OTSUKA HOLDINGS CO., LTD.	17.02x	1.9x	8.99x	1.43%	33.53B
CIPLA LIMITED	26.7x	3.28x	16.8x	0.9%	11.67B
ZYDUS LIFESCIENCES LIMITED	24.25x	4.23x	15.77x	0.73%	11.62B
KRKA, D. D.	19.34x	3.34x	12.18x	3.51%	8.97B
GEDEON RICHTER	8.14x	1.9x	4.98x	5.33%	6.89B
ONO PHARMACEUTICAL CO., LTD.	14.75x	1.94x	7.33x	3.63%	6.55B
GLENMARK PHARMACEUTICALS LIMITED	32.55x	3.7x	15.73x	0.25%	6.32B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	41.52x	-	-	-	5.12B
Average	24.59x	3.41x	13.21x	2.08%	15.07B
Weighted average by Cap.	26.34x	4.18x	15.67x	1.52%